Invention Grant
- Patent Title: Treatment of attention-deficit/hyperactivity disorder
- Patent Title (中): 治疗注意力缺陷/多动障碍
-
Application No.: US12475440Application Date: 2009-05-29
-
Publication No.: US08222278B2Publication Date: 2012-07-17
- Inventor: Earle E. Bain , Walid M. Abi-Saab , Sandeep Dutta , Tushar S. Garimella , Walid M. Awni , Mario D. Saltarelli
- Applicant: Earle E. Bain , Walid M. Abi-Saab , Sandeep Dutta , Tushar S. Garimella , Walid M. Awni , Mario D. Saltarelli
- Applicant Address: US IL Abbott Park
- Assignee: Abbott Laboratories
- Current Assignee: Abbott Laboratories
- Current Assignee Address: US IL Abbott Park
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
Public/Granted literature
- US20100144795A1 TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER Public/Granted day:2010-06-10
Information query
